Skip to main content
NEOGNeogen CorporationSell4.7·$9.57+4.30%
NEOG · Concentration risk · 10-K extracted

Neogen (NEOG) concentration risks

Updated

The most significant concentration Neogen discloses is Food Safety segment at 71.3%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Neogen’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 3 disclosed concentrations

HIGH3
MEDIUM0
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHBuilt-inProduct / Revenue mix
71.3%

Food Safety segment

10-K Item 1: 'Revenues from Neogen's Food Safety segment accounted for 71.3%...of our total revenues for fiscal years ended May 31, 2025'
SEC 10-K · filed Jul 2025
HIGHBuilt-inGeographic
50.2%

international (outside U.S.)

10-K Item 1A: 'In fiscal year 2025, sales to customers outside of the U.S. accounted for 50.2% of our total revenue'
SEC 10-K · filed Jul 2025
HIGHOutside partySupplier

sole or single source supplier

10-K Item 1A: 'Certain of our food safety product lines depend on a sole or single source supplier or vendor'
SEC 10-K · filed Jul 2025
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-06-24

The company's concentration profile is multi-dimensional, combining a segment-level product tilt, a geographic exposure, and a supply-chain dependency. The Food Safety segment generated 71.3% of total revenues in fiscal year 2025 — a high-share structural exposure by disclosed size. The character is structural: the business has been deliberately built around food safety testing and diagnostics, so the segment dominance reflects the company's strategic focus rather than a temporary product mix shift. A prolonged contraction in food safety testing demand or a regulatory change affecting that end-market would affect the majority of the revenue base. Compounding the segment concentration, sales to customers outside of the U.S. accounted for 50.2% of total revenue in fiscal year 2025 — also a high-share structural exposure by disclosed size. The international share is diffuse across geographies rather than tied to a single country, but it still introduces currency translation risk and exposure to varying regulatory and economic conditions across multiple markets. On the supply side, certain food safety product lines depend on a sole or single source supplier or vendor — a high-share dependency by disclosed size. This is the one area where an idiosyncratic, counterparty-specific shock could compress supply availability or margins for specific product lines. Together, the profile features three high-share exposures across different dimensions: product, geography, and supply chain. No single exposure can be dismissed in isolation; the convergence of all three elevates the overall complexity of the risk profile relative to a simpler, single-axis concentration.

For the engine’s reasoning on NEOG’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Medical Devices

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
AORTArtivion, Inc.4408
NEOGNeogen Corporation3003
ATECAlphatec Holdings, Inc.1102
ABTAbbott Laboratories1001
AXGNAxoGen, Inc.0000
BIOBio-Rad Laboratories, Inc.0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks NEOG Concentration risk